Cite

HARVARD Citation

    Dao, B. et al. (n.d.). Combination pertuzumab, trastuzumab, and taxane for metastatic breast cancer after first progression: a single institution's experience. Journal of oncology pharmacy practice. pp. 261-264. [Online]. 
  
Back to record